247 related articles for article (PubMed ID: 14715822)
21. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
Dresner-Pollak R; Karmeli F; Eliakim R; Ackerman Z; Rachmilewitz D
Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.
Dresner Pollack R; Rachmilewitz E; Blumenfeld A; Idelson M; Goldfarb AW
Br J Haematol; 2000 Dec; 111(3):902-7. PubMed ID: 11122154
[TBL] [Abstract][Full Text] [Related]
23. Skeletal status and laboratory investigations in adolescent girls with anorexia nervosa.
Oświecimska J; Ziora K; Pluskiewicz W; Geisler G; Broll-Waśka K; Karasek D; Dyduch A
Bone; 2007 Jul; 41(1):103-10. PubMed ID: 17493887
[TBL] [Abstract][Full Text] [Related]
24. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
Madeddu G; Spanu A; Solinas P; Calia GM; Lovigu C; Chessa F; Mannazzu M; Falchi A; Mura MS; Madeddu G
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003
[TBL] [Abstract][Full Text] [Related]
25. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
[TBL] [Abstract][Full Text] [Related]
26. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
[TBL] [Abstract][Full Text] [Related]
27. Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients.
Mora S; Barera G; Beccio S; Proverbio MC; Weber G; Bianchi C; Chiumello G
Am J Gastroenterol; 1999 Feb; 94(2):398-403. PubMed ID: 10022636
[TBL] [Abstract][Full Text] [Related]
28. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
Sciannamblo M; Russo G; Cuccato D; Chiumello G; Mora S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
[TBL] [Abstract][Full Text] [Related]
29. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study.
Arikoski P; Komulainen J; Riikonen P; Voutilainen R; Knip M; Kröger H
J Clin Endocrinol Metab; 1999 Sep; 84(9):3174-81. PubMed ID: 10487683
[TBL] [Abstract][Full Text] [Related]
30. Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.
Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
J Clin Endocrinol Metab; 2007 Apr; 92(4):1283-8. PubMed ID: 17227801
[TBL] [Abstract][Full Text] [Related]
31. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
[TBL] [Abstract][Full Text] [Related]
32. Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy X-ray absorptiometry measurements.
Pitukcheewanont P; Safani D; Church J; Gilsanz V
Osteoporos Int; 2005 Nov; 16(11):1393-6. PubMed ID: 15702261
[TBL] [Abstract][Full Text] [Related]
33. Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study.
Zhang L; Su Y; Hsieh E; Xia W; Xie J; Han Y; Cao Y; Li Y; Song X; Zhu T; Li T; Yu W
BMC Musculoskelet Disord; 2013 Jul; 14():224. PubMed ID: 23899016
[TBL] [Abstract][Full Text] [Related]
34. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
35. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
[TBL] [Abstract][Full Text] [Related]
36. Bone mineral density in postmenarchal adolescent girls in the United States: associated biopsychosocial variables and bone turnover markers.
Harel Z; Gold M; Cromer B; Bruner A; Stager M; Bachrach L; Wolter K; Reid C; Hertweck P; Nelson A; Nelson D; Coupey S; Johnson C; Burkman R; Bone H
J Adolesc Health; 2007 Jan; 40(1):44-53. PubMed ID: 17185205
[TBL] [Abstract][Full Text] [Related]
37. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
38. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
[TBL] [Abstract][Full Text] [Related]
39. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
Laway BA; Goswami R; Singh N; Gupta N; Seith A
Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral therapy and bone mineral measurements in HIV-infected youths.
Zuccotti G; Viganò A; Gabiano C; Giacomet V; Mignone F; Stucchi S; Manfredini V; Marinacci F; Mora S
Bone; 2010 Jun; 46(6):1633-8. PubMed ID: 20211284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
